News Sentiment

RGO sentiment intelligence

Regeneron Pharmaceuticals, Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 50 Balanced news tone 13 relevant articles
Exchange GER Germany
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 579.30 Week of 10 Jul 2026
Weighted tone 50/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

77/100 classification confidence.

Company focus 13

directly relevant articles

Source quality 4

high-authority source matches

Trend context Trend inactive

+1.3% over one week, +9.6% over four weeks, trend inactive, and below fair value.

Latest direct headline Positive

Prominent construction companies get a portion of Regeneron's $2B Saratoga expansion

Market Reaction

Balanced read

57/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 77/100 classification
One-week reaction 1.3% Price digesting
Trend fit Trend inactive 9.6% over four weeks
Fair value -20.5% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 2
Neutral 8
Negative 3

Relevance

Why the article matched

Direct first
Direct company coverage 13
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
GuruFocus 3
Reuters 3
Stock Titan 2
PR Newswire 2
The Business Journals 1
Market source 1
Seeking Alpha 1

Event Lens

What the news is about

Classified themes
Market update 7
Earnings 3
Macro sensitivity 1
Regulatory and legal 1
Analyst action 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-13 of 13